{"disease":{"id":"regional","name":"regional"},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Regional enteritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"dexamethasone-phosphate","indication_name":"Regional enteritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Dexamethasone Sodium Phosphate","generic_name":"dexamethasone phosphate","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"dactinomycin","indication_name":"Locally Recurrent or Locoregional Solid Malignancies","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cosmegen","generic_name":"DACTINOMYCIN","company_name":"Recordati","drug_phase":"marketed","molecular_target":"DNA","drug_class":"Actinomycin [EPC]","quality_score":65,"revenue":null,"mechanism":"Dactinomycin binds DNA and inhibits RNA synthesis, demonstrating cytotoxic activity in cancer models."},{"drug_id":"chembl-chembl650","indication_name":"Local or Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"METHYLPREDNISOLONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulses by increasing the threshold for electrical excitation, slowing propagation, and reducing the rate of rise of the action potential."},{"drug_id":"chembl-chembl1201577","indication_name":"Locally or regionally advanced SCCHN","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CETUXIMAB","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Epidermal Growth Factor Receptor Antagonist [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl1201577","indication_name":"Recurrent locoregional or metastatic SCCHN","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"CETUXIMAB","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Epidermal Growth Factor Receptor Antagonist [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"chembl-chembl526","indication_name":"Sedation in Combination with Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PROPOFOL","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"General Anesthetic [EPC]","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"ropivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naropin","generic_name":"ROPIVACAINE","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":49,"revenue":null,"mechanism":""},{"drug_id":"mepivacaine","indication_name":"Administration of Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carbocaine","generic_name":"MEPIVACAINE","company_name":"Eastman Kodak","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha","drug_class":"Amide Local Anesthetic","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"bupivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride And Epinephrine","generic_name":"BUPIVACAINE","company_name":"Innocoll","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Amide Local Anesthetic","quality_score":69,"revenue":null,"mechanism":"Bupivacaine works by blocking nerve impulses to prevent pain signals from reaching the brain."},{"drug_id":"fentanyl-f2","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"fentanyl-f2","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fentanyl (F2)","company_name":"Oslo University Hospital","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid","quality_score":33,"revenue":null,"mechanism":""},{"drug_id":"vitamin-k1","indication_name":"Hypoprothrombinemia secondary to regional enteritis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vitamin K1","generic_name":"Phytonadione","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Vitamin K-dependent carboxylase; vitamin K epoxide reductase complex (indirect antagonism of warfarin effects)","drug_class":"Vitamin K [EPC]","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"bupivacain","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Bupivacain","company_name":"Sisli Hamidiye Etfal Training and Research Hospital","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Cytochrome P450 2D6, Potassium channel subfamily K member 3","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"ropivacain","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Ropivacain","company_name":"University Hospital, Basel, Switzerland","drug_phase":"marketed","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropine","company_name":"Rigshospitalet, Denmark","drug_phase":"phase_1","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocaine-hydrochloride","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"fentanyl","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"fentanyl","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duragesic","generic_name":"fentanyl","company_name":"Johnson & Johnson (Janssen Pharmaceutica)","drug_phase":"marketed","molecular_target":"D(4) dopamine receptor, Solute carrier family 22 member 1, D(2) dopamine receptor","drug_class":"Synthetic opioid analgesic","quality_score":55,"revenue":null,"mechanism":"Synthetic opioid 50-100x more potent than morphine that binds mu-opioid receptors, providing potent analgesia and anesthesia."},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"naropeine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Naropeine","company_name":"University Hospital, Rouen","drug_phase":"phase_3","molecular_target":"Potassium channel subfamily K member 3, Sodium channel protein type 1 subunit alpha, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"morphine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":10,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"morphine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MS Contin","generic_name":"morphine sulfate","company_name":"Generic (multiple manufacturers)","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor","drug_class":"Opioid analgesic","quality_score":10,"revenue":null,"mechanism":"The prototypical opioid agonist that binds mu-opioid receptors in the CNS, providing potent analgesia and serving as the reference standard for all opioids."},{"drug_id":"morphine-sulfate","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"morphine-sulfate","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Duramorph Pf","generic_name":"Morphine Sulfate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Mu-type opioid receptor","drug_class":"Opioid Agonist","quality_score":80,"revenue":null,"mechanism":"Duramorph Pf works by binding to opioid receptors in the brain and spinal cord, mimicking the natural pain-relieving chemicals in the body."},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"levobupivacaine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Chirocain","generic_name":"LEVOBUPIVACAINE","company_name":"Purdue Pharma Lp","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"levobupivacaine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"carbocaine","indication_name":"Administration of Regional Anesthesia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Carbocaine","company_name":"Nantes University Hospital","drug_phase":"marketed","molecular_target":"Sodium channel protein type 1 subunit alpha, Sodium channel protein type 2 subunit alpha, Sodium channel protein type 3 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lidocain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Labor Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Ophthalmologic Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Postoperative Pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."},{"drug_id":"bupivacaine-hydrochloride-and-epinephrine","indication_name":"Regional Anesthesia for Surgery","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bupivacaine Hydrochloride","generic_name":"Bupivacaine Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Nerve sodium channels","drug_class":"Amide-type local anesthetic","quality_score":10,"revenue":null,"mechanism":"Bupivacaine blocks nerve impulse generation and conduction by increasing electrical excitation threshold and slowing action potential rise."}],"pipeline":[],"offLabel":[],"totalMarketed":49,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05706688","title":"Effect of Regional Versus General Anesthesia on Thirty-day Outcomes Following Carotid Endarterectomy: a Matched-pairs Cohort Study.","phase":"","overall_status":"COMPLETED","enrollment_count":37204,"lead_sponsor_name":"University of Virginia","has_results":false},{"nct_id":"NCT05579808","title":"Effect of Epidural Analgesia on Labour, Neonatal and Maternal Outcomes.","phase":"","overall_status":"COMPLETED","enrollment_count":21808,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04451642","title":"A Retrospective Clinical Registry of Peripheral Nerve Block","phase":"","overall_status":"COMPLETED","enrollment_count":13816,"lead_sponsor_name":"Instituto de Investigación Sanitaria Aragón","has_results":false},{"nct_id":"NCT00904241","title":"Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT00436696","title":"Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions","phase":"","overall_status":"COMPLETED","enrollment_count":9350,"lead_sponsor_name":"Children's Oncology Group","has_results":false},{"nct_id":"NCT04730310","title":"Anesthesia Technique and Lower Limb Revascularization Patency","phase":"","overall_status":"COMPLETED","enrollment_count":8893,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06829108","title":"Association of Transversus Abdominis Plane Block (TAPB) with Postoperative Delirium (POD) in Elderly Patients Undergoing Major Gastrointestinal Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":5220,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06460792","title":"Ultrasound-guided Peripheral Nerve Blocks - a Database","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Nordsjaellands Hospital","has_results":false},{"nct_id":"NCT07238933","title":"Neurological Events and Unforeseen Risks After Locoregional-anesthesia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":3396,"lead_sponsor_name":"Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva","has_results":false},{"nct_id":"NCT07426094","title":"PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate Cancer","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":1600,"lead_sponsor_name":"Affidea Nu-med Center of Oncological DIagnostics and Therapy","has_results":false},{"nct_id":"NCT03754374","title":"Health Care Access for Asylum Seekers in Brittany : Description, Associated Factors and Levers of Improvement","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT00026312","title":"Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1449,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT04197752","title":"Regional Anesthesia and Analgesia Techniques in Obese Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT05777694","title":"Postdural Punction Headache After Ceserian Section","phase":"NA","overall_status":"COMPLETED","enrollment_count":750,"lead_sponsor_name":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","has_results":false},{"nct_id":"NCT03923751","title":"Survey of Regional Anesthesia Practice in Poland","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT00567567","title":"Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":665,"lead_sponsor_name":"Children's Oncology Group","has_results":true},{"nct_id":"NCT02972359","title":"Safety of Intravenous Neridronic Acid in CRPS","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Grünenthal GmbH","has_results":true},{"nct_id":"NCT05491239","title":"Optimal Postoperative Pain Management After Lung Surgery (OPtriAL)","phase":"NA","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"Maxima Medical Center","has_results":false},{"nct_id":"NCT02800863","title":"TARGET Post-Approval Study","phase":"","overall_status":"COMPLETED","enrollment_count":426,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT06927193","title":"Regional Analgesia at the Pediatric Emergency Department","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"Hillel Yaffe Medical Center","has_results":false},{"nct_id":"NCT06053476","title":"Optimal Postoperative Chest Tube and Pain Management in Patients Surgically Treated for Primary Spontaneous Pneumothorax (Pneumotrial)","phase":"NA","overall_status":"RECRUITING","enrollment_count":366,"lead_sponsor_name":"Maxima Medical Center","has_results":false},{"nct_id":"NCT03835234","title":"Incidence and Factors Associated With PONV in Regional Anaesthesia","phase":"","overall_status":"COMPLETED","enrollment_count":364,"lead_sponsor_name":"Makerere University","has_results":false},{"nct_id":"NCT05814497","title":"Supraspinal Processing of Sensory Aspects of Pain","phase":"NA","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"Children's Hospital Medical Center, Cincinnati","has_results":false},{"nct_id":"NCT06121726","title":"Predictive Factors for the Effectiveness of the Ilioinguinal Iliohypogastric Nerve Block for Hernia Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"University of Padova","has_results":false},{"nct_id":"NCT06793527","title":"Comparison of the Efficacy of Celiac Plexus Blockade, ESP and Lidocaine Infusion Under OFA","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Jagiellonian University","has_results":false},{"nct_id":"NCT06224439","title":"Comparison of Regional Anaesthesia Methods for Femoral Neck Fracture Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Bursa Yuksek Ihtisas Training and Research Hospital","has_results":false},{"nct_id":"NCT06120088","title":"U.S. Guided Erector Spinae Block for Postoperative Pain Management in Paraumbilical Hernia Repair Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT07190443","title":"Adjuvant Abemaciclib for Locoregional Recurrence of HR-positive, HER2-negative Breast Cancer (JCOG2313, AURA)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":290,"lead_sponsor_name":"Japanese Foundation for Cancer Research","has_results":false},{"nct_id":"NCT03560986","title":"Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":267,"lead_sponsor_name":"Grünenthal GmbH","has_results":true},{"nct_id":"NCT05988112","title":"Locoregional Recurrence of Breast Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":265,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT01010126","title":"Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":252,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT05067985","title":"SARS-CoV-2 PANDEMIC AND FAILED SPINAL ANESTHESIA","phase":"","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT05085652","title":"Spinal Anesthesia Related Hypotension in SARS-CoV-2 (COVID-19) Pregnant Patients","phase":"","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT05416541","title":"Uncontrolled Disinformation About Regional Anesthesia and Pregnant Patients.","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Ankara City Hospital Bilkent","has_results":false},{"nct_id":"NCT05233462","title":"Height Adjusted Versus Standardized Dose of Bupivacaine for Spinal Anesthesia","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"University Hospital, Caen","has_results":false},{"nct_id":"NCT03618459","title":"Post-discharge Pain After Breast-surgery Treated by Paravertebral Block","phase":"","overall_status":"COMPLETED","enrollment_count":244,"lead_sponsor_name":"Samuele Ceruti","has_results":false},{"nct_id":"NCT07392827","title":"Pediatric Postoperative Pain Management","phase":"","overall_status":"COMPLETED","enrollment_count":219,"lead_sponsor_name":"Hacettepe University","has_results":false},{"nct_id":"NCT07303283","title":"Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":218,"lead_sponsor_name":"Kai Hu","has_results":false},{"nct_id":"NCT04252820","title":"Prevention of Perioperative Hypothermia in Transurethral Resection Under Spinal Anaesthesia","phase":"NA","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Dr. Negrin University Hospital","has_results":false},{"nct_id":"NCT06115720","title":"Consent in Anaesthesia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":206,"lead_sponsor_name":"Imperial College Healthcare NHS Trust","has_results":false},{"nct_id":"NCT06439953","title":"Irrisept Solution for Instrumented Spine Surgery","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Rhode Island Hospital","has_results":false},{"nct_id":"NCT05108103","title":"Determination of Longus Colli Muscle Thickness by Ultrasonography","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT07326644","title":"Effect of Gestational Weight Gain on Spinal Anesthesia in Elective Cesarean Delivery","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Elazıg Fethi Sekin Sehir Hastanesi","has_results":false},{"nct_id":"NCT04199442","title":"Anxiety Assessment Before Regional Anesthesia.","phase":"","overall_status":"TERMINATED","enrollment_count":200,"lead_sponsor_name":"University of Liege","has_results":false},{"nct_id":"NCT05467891","title":"Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Oana Danciu","has_results":false},{"nct_id":"NCT03117894","title":"PECS-2 for Breast Surgery","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT05924282","title":"PET on Surgery for Loco-regionally Recurrent Colorectal Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":193,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT05478629","title":"Safety of Regional Anesthesia in Ukraine: the Survey","phase":"","overall_status":"UNKNOWN","enrollment_count":182,"lead_sponsor_name":"Bogomolets National Medical University","has_results":false},{"nct_id":"NCT03530345","title":"Efficacy and Safety of Intravenous Neridronic Acid in CRPS","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":182,"lead_sponsor_name":"Grünenthal GmbH","has_results":true},{"nct_id":"NCT03740399","title":"Effect of Modified 45-degree Head-up Tilt Position in Cesarean Operation to the Success of Spinal Anesthesia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Trakya University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}